This observational pilot study aims to establish criteria for evaluating the effectiveness of hemoadsorption with the Efferon LPS device in adult patients with burn injury. Participants will be prospectively enrolled into the treatment group and compared with a retrospectively selected control group. Each patient in the treatment group will undergo two hemoadsorption sessions, each lasting 6-12 hours, with a 24 hours interval between sessions. The procedures may be performed in combination with hemofiltration or hemodiafiltration at the investigator's discretion.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-21; most recent amendment 2026-01-21.
Status change: Not Yet Recruiting → Recruiting2026-01-21